ADVB
Advanced Biomed Inc.Price
Daily candles with volume. Pins mark insider trades, rating changes, 13F stakes, reports, catalysts and short-interest jumps.
- X Jul 15 Short interest falls 31.3% to 10.6K
- X Jul 31 Short interest jumps 441.2% to 57.2K
- X Aug 14 Short interest falls 34.7% to 37.4K
- X Aug 31 Short interest falls 56.2% to 16.4K
- X Sep 15 Short interest falls 39.8% to 9.8K
- X Sep 30 Short interest jumps 92.0% to 18.9K
- E Oct 19 Trading halt: Halt Resumed: ADVB — trading resumed after LUDP (Volatilit…
- E Oct 19 Trading halt: Trading Halt: ADVB — LUDP (Volatility Trading Pause)
Signal stack
Where each data set points today.
- InsidersNO TRADES
No open-market buys or sells in 12 months. Recent filings are awards, exercises and tax withholding.
- Short sellersBUILDING
Short interest +92.0% to 18.9K shares. 1.0 days to cover, ≈1.1% of shares.
- TrendDOWNTREND
55% below its 50-day average. New closing low $3.17 on Oct 23.
Insider ledger
Form 4| Date | Insider | Type | Value |
|---|---|---|---|
| Jul 27, 2026 | Pau Hung To 10%+ Owner | OTHER | $36.6B |
| Jul 27, 2026 | Pau Hung To 10%+ Owner | OTHER | $48.0B |
Earnings setup
EstimatesRevision history: 🔒 Fresh data — subscribers only
| Period | EPS est. | Range | 30D rev. | Revenue |
|---|---|---|---|---|
| Current Q | 🔒 Fresh data — subscribers only | |||
| Next Q | 🔒 Fresh data — subscribers only | |||
| Current FY | 🔒 Fresh data — subscribers only | |||
| Next FY | 🔒 Fresh data — subscribers only | |||
Short side
FINRA· Sep 30, 2026| Oct 19, 2026 | Volatility Pause | Resumed |
| Jul 30, 2026 | Volatility Pause | Resumed |
| Jul 27, 2026 | Volatility Pause | Resumed |
| Jul 24, 2026 | Volatility Pause | Resumed |
| Jul 23, 2026 | Volatility Pause | Resumed |
SecBot reports
3 filings · 0 bullish · 1 bearish · 2 neutral- NEUTRAL SC 13GSep 22, 2026
Advance On Ventures Ltd and its director Chen Yi Lee filed a Schedule 13G disclosing a combined…
Monitor for any conversion to a 13D or increase in stake above 10%, which would signal a shift from passive to active intent. The small float and insider-related nature of this filing suggest…
- NEUTRAL 8-KJul 17, 2026
Advanced Biomed terminated its $25M equity line of credit (ELOC) with Helena Global Investment…
The termination removes a potential dilutive overhang, which is mildly positive for existing shareholders. However, the company's capital needs are unclear given its $8M market cap. Monitor for any…
- BEARISH 8-KJul 3, 2026
Advanced Biomed Inc. (ADVB) agreed to sell 100% of its Taiwan subsidiary, which houses its…
The sale signals a strategic shift away from biomedical R&D toward AI, but the small cash consideration raises questions about the value of the divested assets. Monitor for closing conditions and…
All ADVB filing & press-release reports (3)
- SC 13G reportSep 22, 2026
- 8-K reportJul 17, 2026
- 8-K reportJul 3, 2026